(a).
30-day survivala (n = 40,478) | 1-year survivala (if they survived to 30 days; n = 39,227) | 5-year survivala (if they survived to 1 year; n = 36,020) | |||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p | HR | 95% CI | p | HR | 95% CI | p | |
R nonobese, D nonobese | Ref. | Ref. | Ref. | ||||||
R nonobese, D obese | 1.02 | (0.86, 1.21) | 0.823 | 0.91 | (0.82, 1.01) | 0.076 | 1.03 | (0.94, 1.13) | 0.493 |
R obese, D nonobese | 1.09 | (0.94, 1.25) | 0.247 | 0.86 | (0.78, 0.94) | 0.001 | 0.92b | (0.85, 1.00) | 0.039 |
R obese, D obese | 1.38b,c | (1.16, 1.65) | <0.001 | 0.84 | (0.74, 0.95) | 0.007 | 0.90b | (0.81, 1.02) | 0.088 |
aCox proportional hazards model. bStatistically significant difference relative to “R nonobese, D obese” group. cStatistically significant difference relative to “R obese, D nonobese” group.
All models are adjusted for D and R gender, D and R race, D and R age, R diagnosis, D and R diabetes history, D and R serum creatinine, D and R bilirubin, R INR, albumin, and MELD score at LT, and D SGOT and SGPT, acute rejection, PVT, and cold ischemia time. LT = liver transplantation, R = recipient, D = donor, HR = hazard ratio, and CI = confidence interval.